Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research ID

hum0589-v1Release info

Latest

Research title

Understanding the Pathogenesis of Spondyloarthritis and Elucidating the Mechanisms Underlying Treatment Resistance Through Integrated Analysis

Research overview

Aims
To elucidate the immunological characteristics of HLA-B27-positive and -negative cases among axial spondyloarthritis and to establish a foundation for precision medicine.
Methods
Cryopreserved peripheral blood mononuclear cells were thawed, and following Fc blocking, flow cytometry antibody, CITE-seq antibodies and dead cell staining were performed. 10,000 live CD45-positive cells were recovered using a MoFlo XDP cell sorter (Beckman Coulter, Brea, USA). A single-cell library was constructed from the recovered cells using the Chromium Single Cell 5' v2 Dual Index protocol (10x Genomics, Pleasanton, USA), and sequencing was performed on the NovaSeq 6000 platform (Illumina, San Diego, USA). The obtained data were mapped using CellRanger (version 6.1.2) with GRCh38 as the reference and objectified using Seurat (version 5.1.0).
Participants/materials
70 patients with spondyloarthritis and 7 HLA-B27-positive uveitis patients as the control
URL
N/A

Datasets

CartDataset IDType of dataPlatformsAccess criteriaDate published
JGAD001075NGS (CITE-seq)
  • Illumina NovaSeq 6000
Controlled-access (Type I)

Data provider

Principal investigator
Keishi Fujio
Affiliation
Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo

Research projects

NameURL

Grants

NameTitleProject number
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED)
Clinical Applications of the IL-17A Vaccine (FPP003) for the Treatment of Spondyloarthritis
  • JP23ek0109565h
Biobank - Construction and Utilization biobank for genomic medicine REalization (B-Cure), Japan Agency for Medical Research and Development (AMED)
Construction of stratification and prognosis prediction models from immunemediated disease genomic information using immune cell eQTL data
  • JP21tm0424221
Moonshot Research and Development Program, Japan Agency for Medical Research and Development (AMED)
Quantum technology and neuromodulation medicine for new therapeutic strategies to suppress microinflammations
  • JP21zf0127004
Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)
Molecular mechanisms of pathogenesis of stress-induced disease and development of stress biomarker detection technology
  • JP24gm1910005
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Integrative multi-omics analysis of autoimmune diseases based on single cell RNA-sequencing of inflammatory organs
  • JP22ek0410074
Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)
Construction of a prognostic model for early rheumatoid arthritis using synovium and peripheral blood information
  • JP24ek0410109
Japan Initiative for World-leading Vaccine Research and Development Centers, Japan Agency for Medical Research and Development (AMED)
Japan Initiative for World-leading Vaccine Research and Development Centers
  • JP223fa627001
Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)
Study of T cell subsets associated with immune memory for both cytotoxic and adaptive immune responses in autoimmune diseases
  • JP23gm1810005
Medical Researcher Development Program, Japan Agency for Medical Research and Development (AMED)
Research Capacity Improvement Plan for The University of Tokyo Hospital
  • JP256f0137004
Cross-ministerial Strategic Innovation Promotion Program (SIP), Council for Science, Technology and Innovation (CSTI)
Integrated Healthcare System
  • JPSIP2023A1
KAKENHI Grant-in-Aid for Scientific Research (C)
Research for pathogenesis of psoriatic arthritis and palmoplantar pustulosis osteoarthritis by single-cell analysis in joint inflammation
  • 22K08539
The JCR Grant for Promoting Basic Rheumatology
N/A

    Related publications

    TitleDOIDataset ID
    Type I Interferon-Associated CD4+ T Cell Responses Characterize HLA-B27-Negative Spondyloarthritis with Axial Involvement

    Controlled access users

    No use of the controlled access data has been recorded.